These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 26826269)

  • 1. Copper delivery to the CNS by CuATSM effectively treats motor neuron disease in SOD(G93A) mice co-expressing the Copper-Chaperone-for-SOD.
    Williams JR; Trias E; Beilby PR; Lopez NI; Labut EM; Bradford CS; Roberts BR; McAllum EJ; Crouch PJ; Rhoads TW; Pereira C; Son M; Elliott JL; Franco MC; Estévez AG; Barbeito L; Beckman JS
    Neurobiol Dis; 2016 May; 89():1-9. PubMed ID: 26826269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.
    Watanabe M; Dykes-Hoberg M; Culotta VC; Price DL; Wong PC; Rothstein JD
    Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading.
    Subramaniam JR; Lyons WE; Liu J; Bartnikas TB; Rothstein J; Price DL; Cleveland DW; Gitlin JD; Wong PC
    Nat Neurosci; 2002 Apr; 5(4):301-7. PubMed ID: 11889469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CuATSM Protects Against the In Vitro Cytotoxicity of Wild-Type-Like Copper-Zinc Superoxide Dismutase Mutants but not Mutants That Disrupt Metal Binding.
    Farrawell NE; Yerbury MR; Plotkin SS; McAlary L; Yerbury JJ
    ACS Chem Neurosci; 2019 Mar; 10(3):1555-1564. PubMed ID: 30462490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of mutant SOD1 on protein structure of skeletal muscle and spinal cord of familial amyotrophic lateral sclerosis: role of chaperone network.
    Wei R; Bhattacharya A; Hamilton RT; Jernigan AL; Chaudhuri AR
    Biochem Biophys Res Commun; 2013 Aug; 438(1):218-23. PubMed ID: 23886956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1.
    Tokuda E; Okawa E; Watanabe S; Ono S
    Hum Mol Genet; 2014 Mar; 23(5):1271-85. PubMed ID: 24163136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
    Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
    Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over-expression of Hsp27 does not influence disease in the mutant SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Krishnan J; Vannuvel K; Andries M; Waelkens E; Robberecht W; Van Den Bosch L
    J Neurochem; 2008 Sep; 106(5):2170-83. PubMed ID: 18624915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological effects of CCS in the absence of SOD1 enzyme activation: implications for disease in a mouse model for ALS.
    Proescher JB; Son M; Elliott JL; Culotta VC
    Hum Mol Genet; 2008 Jun; 17(12):1728-37. PubMed ID: 18337307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immature copper-zinc superoxide dismutase and familial amyotrophic lateral sclerosis.
    Seetharaman SV; Prudencio M; Karch C; Holloway SP; Borchelt DR; Hart PJ
    Exp Biol Med (Maywood); 2009 Oct; 234(10):1140-54. PubMed ID: 19596823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
    Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of intracellular copper homeostasis is common to transgenic mice expressing human mutant superoxide dismutase-1s regardless of their copper-binding abilities.
    Tokuda E; Okawa E; Watanabe S; Ono S; Marklund SL
    Neurobiol Dis; 2013 Jun; 54():308-19. PubMed ID: 23321002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copper chaperone for superoxide dismutase is essential to activate mammalian Cu/Zn superoxide dismutase.
    Wong PC; Waggoner D; Subramaniam JR; Tessarollo L; Bartnikas TB; Culotta VC; Price DL; Rothstein J; Gitlin JD
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2886-91. PubMed ID: 10694572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effect of CuATSM on neurotoxin-induced motor neuron loss in an ALS mouse model.
    Kuo MTH; Beckman JS; Shaw CA
    Neurobiol Dis; 2019 Oct; 130():104495. PubMed ID: 31181282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous Cu in the central nervous system fails to satiate the elevated requirement for Cu in a mutant SOD1 mouse model of ALS.
    Hilton JB; White AR; Crouch PJ
    Metallomics; 2016 Sep; 8(9):1002-11. PubMed ID: 27357743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cells Overexpressing ALS-Associated SOD1 Variants Are Differentially Susceptible to CuATSM-Associated Toxicity.
    Brown ML; McAlary L; Lum JS; Farrawell NE; Yerbury JJ
    ACS Chem Neurosci; 2022 Aug; 13(16):2371-2379. PubMed ID: 35900338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with the copper compound CuATSM has no significant effect on motor neuronal pathology in patients with ALS.
    Yang Y; Rowe D; McCann H; Shepherd CE; Kril JJ; Kiernan MC; Halliday GM; Tan RH
    Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12919. PubMed ID: 37317638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models.
    Jonsson PA; Graffmo KS; Andersen PM; Brännström T; Lindberg M; Oliveberg M; Marklund SL
    Brain; 2006 Feb; 129(Pt 2):451-64. PubMed ID: 16330499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal dysfunction of the proteasome: a pathogenic factor in a mouse model of amyotrophic lateral sclerosis.
    Kabashi E; Agar JN; Taylor DM; Minotti S; Durham HD
    J Neurochem; 2004 Jun; 89(6):1325-35. PubMed ID: 15189335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zn II(atsm) is protective in amyotrophic lateral sclerosis model mice via a copper delivery mechanism.
    McAllum EJ; Roberts BR; Hickey JL; Dang TN; Grubman A; Donnelly PS; Liddell JR; White AR; Crouch PJ
    Neurobiol Dis; 2015 Sep; 81():20-4. PubMed ID: 25766674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.